Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.
Curadel Surgical Innovations has raised $14.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2025.
Curadel Surgical Innovations is headquartered in Natick, United States.
Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for image-guided surgery.
Curadel Surgical Innovations is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curadel Surgical Innovations — Funding & Investors." VCBacked, October 9, 2025, https://www.vcbacked.co/company/curadel-surgical-innovations. Accessed August 14, 2026.
VCBacked. (2025). Curadel Surgical Innovations — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/curadel-surgical-innovations
{{cite web |title=Curadel Surgical Innovations — Funding & Investors |url=https://www.vcbacked.co/company/curadel-surgical-innovations |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated